Literature DB >> 17182042

Heat shock protein 70 inhibits the nuclear import of apoptosis-inducing factor to avoid DNA fragmentation in TF-1 cells during erythropoiesis.

Julian Chun-Kin Lui1, Siu-Kai Kong.   

Abstract

Loss of mitochondrial membrane potential (DeltaPsi(m)) and release of AIF (apoptosis-inducing factor) from mitochondria are key steps in apoptosis. In TF-1 model, DeltaPsi(m) was depolarized with AIF release during erythroid development. Yet, no DNA fragmentation was observed. When DeltaPsi(m) depolarization had been blocked, erythropoiesis was suppressed. Interestingly, heat shock protein 70 (Hsp70) was found transiently upregulated during depolarization and it retained AIF in the cytosol to avoid DNA damages. When Hsp inhibitor was added, DNA fragmentation occurred. We show this mechanism for the first time in erythropoiesis how cells with DeltaPsi(m) depolarization and AIF release escape apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182042     DOI: 10.1016/j.febslet.2006.11.082

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Increased stability of Bcl-2 in HSP70-mediated protection against apoptosis induced by oxidative stress.

Authors:  Bimei Jiang; Pengfei Liang; Gonghua Deng; Zizhi Tu; Meidong Liu; Xianzhong Xiao
Journal:  Cell Stress Chaperones       Date:  2010-10-03       Impact factor: 3.667

Review 2.  Chaperoning erythropoiesis.

Authors:  Mitchell J Weiss; Camila O dos Santos
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

Review 3.  Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27.

Authors:  David Lanneau; Aurelie de Thonel; Sebastien Maurel; Celine Didelot; Carmen Garrido
Journal:  Prion       Date:  2007-01-24       Impact factor: 3.931

4.  The severe phenotype of Diamond-Blackfan anemia is modulated by heat shock protein 70.

Authors:  Marc Gastou; Sarah Rio; Michaël Dussiot; Narjesse Karboul; Hélène Moniz; Thierry Leblanc; Margaux Sevin; Patrick Gonin; Jérome Larghéro; Carmen Garrido; Anupama Narla; Narla Mohandas; William Vainchenker; Olivier Hermine; Eric Solary; Lydie Da Costa
Journal:  Blood Adv       Date:  2017-10-10

Review 5.  Apoptosis-inducing factor: structure, function, and redox regulation.

Authors:  Irina F Sevrioukova
Journal:  Antioxid Redox Signal       Date:  2011-03-10       Impact factor: 8.401

6.  Age-dependent alpha-synuclein accumulation is correlated with elevation of mitochondrial TRPC3 in the brains of monkeys and mice.

Authors:  Min Chen; Jia Liu; Yongquan Lu; Chunli Duan; Lingling Lu; Ge Gao; Piu Chan; Shun Yu; Hui Yang
Journal:  J Neural Transm (Vienna)       Date:  2016-11-30       Impact factor: 3.575

Review 7.  Targeting Hsp70: A possible therapy for cancer.

Authors:  Sanjay Kumar; James Stokes; Udai P Singh; Karyn Scissum Gunn; Arbind Acharya; Upender Manne; Manoj Mishra
Journal:  Cancer Lett       Date:  2016-02-17       Impact factor: 8.679

8.  Role of Apoptotic Proteins in REC-2006 Mediated Radiation Protection in Hepatoma Cell Lines.

Authors:  Pankaj Kumar Singh; Raj Kumar; Ashok Sharma; Rajesh Arora; Raman Chawla; Swatantra Kumar Jain; Rajendra Prasad Tripathi; Rakesh Kumar Sharma
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-20       Impact factor: 2.629

9.  Prediction of localization and interactions of apoptotic proteins.

Authors:  Miroslav Varecha; Michal Zimmermann; Jana Amrichová; Vladimír Ulman; Pavel Matula; Michal Kozubek
Journal:  J Biomed Sci       Date:  2009-07-06       Impact factor: 8.410

10.  A multi-center study on the regenerative effects of erythropoietin in burn and scalding injuries: study protocol for a randomized controlled trial.

Authors:  Christina Irene Günter; Augustinus Bader; Ulf Dornseifer; Silvia Egert; Sebastian Dunda; Gerrit Grieb; Thomas Wolter; Norbert Pallua; Tobias von Wild; Frank Siemers; Peter Mailänder; Oliver Thamm; Carsten Ernert; Michael Steen; Reiner Sievers; Bert Reichert; Afshin Rahmanian-Schwarz; Hans Schaller; Bernd Hartmann; Max Otte; Victoria Kehl; Christian Ohmann; Wolfgang Jelkmann; Hans-Günther Machens
Journal:  Trials       Date:  2013-05-03       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.